Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.
about
Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Combined use of Saccharomyces ...... against POLG-related diseases.
@en
Combined use of Saccharomyces ...... against POLG-related diseases.
@nl
type
label
Combined use of Saccharomyces ...... against POLG-related diseases.
@en
Combined use of Saccharomyces ...... against POLG-related diseases.
@nl
prefLabel
Combined use of Saccharomyces ...... against POLG-related diseases.
@en
Combined use of Saccharomyces ...... against POLG-related diseases.
@nl
P2093
P2860
P356
P1476
Combined use of Saccharomyces ...... against POLG-related diseases.
@en
P2093
Agnès Delahodde
Celine Rodier
Laras Pitayu
Tiziana Lodi
P2860
P304
P356
10.1093/HMG/DDV509
P577
2015-12-21T00:00:00Z